Back
Alkermes PLC Vs. Avidity Biosciences Industry Stock Comparison
Sell
49
ALKS
Alkermes PLC
Last Price:
$34.61
Seasonality Move:
2.42%
Sell
25
RNA
Avidity Biosciences
Last Price:
$30.84
Seasonality Move:
0%
Sell
49
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
-
The current Alkermes PLC [ALKS] share price is $34.60. The Score for ALKS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $30.84. The Score for RNA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $34.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALKS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $30.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.
ALKS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 55.2 | Buy |
| Chaikin Money Flow: | 3452743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9 - 35.44) | Sell |
| Bollinger Bands (100): | (28.05 - 33.41) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 48.83 | Sell |
| Chaikin Money Flow: | 549842 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.62 - 32.34) | Sell |
| Bollinger Bands (100): | (29.04 - 41.76) | Sell |
ALKS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.08 | Buy |
| 20-day SMA: | 34.48 | Buy |
| 50-day SMA: | 32.52 | Buy |
| 200-day SMA: | 28.56 | Buy |
| 8-day EMA: | 34.27 | Buy |
| 20-day EMA: | 34.12 | Buy |
| 50-day EMA: | 32.92 | Buy |
| 200-day EMA: | 29.7 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.69 | Sell |
| 20-day SMA: | 30.67 | Buy |
| 50-day SMA: | 31.11 | Sell |
| 200-day SMA: | 38.69 | Sell |
| 8-day EMA: | 31.19 | Sell |
| 20-day EMA: | 31.15 | Sell |
| 50-day EMA: | 32.04 | Sell |
| 200-day EMA: | 33.88 | Sell |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.96 per share, and a decrease next year of $0.48 per share.
Alkermes PLC Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||